Remifentanil versus Fentanyl for pain control during elective endotracheal intubation for surfactant administration in preterm infants
Remifentanil versus Fentanyl for pain control during elective endotracheal intubation for surfactant administration in preterm infants
نویسندگان: محمدباقر حسینی , کیوان میرنیا , مرتضی قوجازاده , مهین سید حجازی , بابک اهرچی فرشی
کلمات کلیدی: Keywords
Preterm infants, endotracheal intubation, Fentanyl,
Remifentanil, Premature Infant Pain Profle –
Revised, surfactant.
نشریه: 0 , 2018;7(2):e070214 , 2018;7(2):e070214 , 2018
| نویسنده ثبت کننده مقاله |
بابک اهرچی فرشی |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
کمیته تحقیقات دانشجویی |
| کد مقاله |
63638 |
| عنوان فارسی مقاله |
Remifentanil versus Fentanyl for pain control during elective endotracheal intubation for surfactant administration in preterm infants |
| عنوان لاتین مقاله |
Remifentanil versus Fentanyl for pain control during elective endotracheal intubation for surfactant administration in preterm infants |
| ناشر |
7 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
خیر |
| عنوان نشریه (خارج از لیست فوق) |
Journal of Pediatric and Neonatal Individualized Medicine |
| نوع مقاله |
Original Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح یک – ISI - Web of Science |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
|
| Abstract
Introduction: Today, the reality of pain in neonates is an undisputed fact,
but pain management in clinical practice remains a challenging issue. All
neonatal units should have a pain management protocol. The aim of this study
was to compare the effectiveness of Remifentanil versus Fentanyl in pain
control during elective endotracheal intubation for surfactant administration
in preterm infants.
Materials and methods: Preterm infants with gestational age between 28
weeks and 34 weeks + 6 days with Respiratory Distress Syndrome (RDS) who
needed surfactant administration were divided into two groups using a random
sampling method. Neonates in the frst group received 2 μg/kg intravenous
Fentanyl infusion and neonates in group 2 received 1 μg/kg intravenous
Remifentanil before elective endotracheal intubation for surfactant therapy.
The vital signs, including heart rate, oxygen saturation, mean arterial blood
pressure and change in facial grimace were documented in an unnamed
Premature Infant Pain Profle-Revised (PIPP-R) scoring sheet individually.
Video recording was performed in both groups before, during and after the
endotracheal intubation. All videos and data were interpreted and scored by
two Newborn Individualized Developmental Care and Assessment Program
(NIDCAP) professionals.
Results: The mean PIPP-R score in the
Fentanyl-treated group was 13.06 ± 3.55 and in
the Remifentanil-treated group was 10.75 ± 2.93,
with no statistically signifcant difference (p =
0.054). There was less need for Naloxone use in
the Remifentanil group (p < 0.001). Incidence of
apnea, severe drop in oxygen saturation, IntraVentricular Hemorrhage (IVH) and chest rigidity
were not signifcantly different between the two
groups.
Conclusion: Although the difference was not
statistically signifcant, Remifentanil reduced the
pain score more than Fentanyl during elective
endotracheal intubation in preterm infants. We
recommend conducting further studies with larger
study populations to determine the better drug and
the optimal dosage of these drugs in neonates. |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| Remifentanil versus Fentanyl for pain control during elective endotracheal intubation for surfactant administration in preterm infants.pdf | 1397/05/20 | 1305145 | دانلود |